Dr. William Joseph Jawien, MD

Dr. Jawien practices at Ccare in Fresno, California.

Dr. Jawien's NPI, 1417904020, was assigned on May 28, 2006. Dr. Jawien graduated from Loyola University Chicago Stritch School of Medicine in 1991. Dr. Jawien holds California license G74904.

Dr. Jawien's primary practice is Ccare, at 7130 N Millbrook Ave, Fresno, CA 93720-3347. The practice phone is (559) 326-1222.

Dr. Jawien's primary practice is Ccare in Fresno, California. Dr. Jawien is also affiliated with Saint Agnes Medical Center. The medical group on file is California Cancer Associates for Research and Excellence (cCARE). Dmand AI also links Dr. Jawien to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jawien practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jawien's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jawien is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Jawien's licenses on file in 2 states: California and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Jawien treats.

CMS data shows 226,451 Medicare services from Dr. Jawien across 73 procedure codes in 2024, for 870 Medicare patients. Medicare paid $1,955,352 for them.

CMS counts 870 Medicare patients who saw Dr. Jawien in 2024. The largest group is 65 to 74, with 330 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jawien's median patient age at 68, with 61% women.

In 2024, Dr. Jawien wrote 1,728 Medicare Part D claims for 228 patients. 71% of them were for generic drugs. CMS names the drug for 1,341 of them, across 42 drugs with 11 or more claims each, at $2,662,993 in total drug cost. In 2023, CMS named 1,211 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jawien for performance year 2024, reported as part of a group. Dr. Jawien accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jawien as offering telehealth.

Dmand AI links Dr. Jawien to 1 clinical trial. Conditions studied include Thrombocythemia, Essential and Thrombocytosis.

CMS Open Payments shows 909 general payments to Dr. Jawien from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Incyte Corporation paid the most, $3,563.

Dmand AI lists 1 award for Dr. Jawien, most recently CMS Stage 1 EHR in 2012.

Dr. Jawien graduated from Loyola University Chicago Stritch School of Medicine in 1991. Dr. Jawien is a member of ACP.

Dr. Jawien is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.